MedTrace Logo

Neurobiological Analyses Within the FORESEE III Study

NCT04021823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-11-10

No results posted yet for this study

Summary

In this observational, non-invasive clinical study different neurobiological analyses will be performed in a group of patients with severe treatment resistant major depression participating in an efficacy study of deep brain stimulation of the superolateral branch of the medial forebrain bundle (slMFB) - FORESEE III.

Conditions

Sponsors & Collaborators

  • German Center for Neurodegenerative Diseases (DZNE)

    collaborator OTHER

  • University Medical Center Freiburg

    collaborator OTHER

  • University Hospital, Bonn

    collaborator OTHER

  • University of Freiburg

    collaborator OTHER

  • University Hospital Freiburg

    lead OTHER

Principal Investigators

  • Thomas E. Schläpfer, Prof. Dr. · University of Freiburg

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2022-06-30
Completion
2023-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021823 on ClinicalTrials.gov